Valuation (59%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -219.27 | 5.94 |
PEG Ratio (TTM) | -2.28 | -0.51 |
P/S Ratio (TTM) | 1.21 | 5.47 |
P/B Ratio (TTM) | 3.45 | 17.80 |
P/FCF Ratio (TTM) | 7.55 | 15.71 |
Price to 5YR AVG Earnings Ratio | 3.88 | 25.36 |
Price to 5YR AVG FCF Ratio | 1.37 | 13.61 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.50% | 5.67% |
ROE (TTM) | -1.44% | 55.75% |
Net Profit Margin (TTM) | -0.55% | -132.78% |
ROIC 5YR AVG | 21.01% | -118.25% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -78.27% | 282.86% | 117.94% |
Revenue | 0.29% | 3.34% | 4.78% |
Net Income | -78.57% | 283.44% | 118.32% |
Cash Flow | 251.50% | 62.37% | 17.87% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.19 | 1.64 |
Quick Ratio (TTM) | 0.95 | 1.37 |
D/E Ratio (TTM) | 0.42 | 1.49 |
Interest Coverage (TTM) | 3.69 | 9.80 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 1.21 | 5.95 |
LTL to 5YR AVG FCF | 1.78 | 1.56 |
Shares Outstanding Growth 5YR AVG | 0.24% | 0.33% |